About Our Leadership team
Our leadership's experience and knowledge about the pharmaceutical industry is unmatched by other CDMO's. We are comprised of the foremost leaders and innovators for development and manufacturing in transdermal, oral thin film, and topical drug delivery. Many of our leaders have come from a pharmaceutical maker background. From business development to manufacturing, our leaders utilize their experience to leverage exceptional outcomes for our clients.
BOB KLAS, JR.
Robert C. (Bob) Klas, Jr. is CEO of Tapemark. Since joining the company in 1985, Bob’s leadership has guided Tapemark’s transition from a regionally based supplier to a global partner of leading companies in the pharmaceutical, medical device, and consumer products markets. Bob became CEO in 2006, having served as President of Tapemark since 1991.
A graduate of Hamline University and William Mitchell College of Law, Bob began his career in banking, first at the former First Bank and later with Norwest Bank (now Wells Fargo), where he managed their residential real estate lending in Minnesota, Western Wisconsin, and Northern Iowa.
A lifelong resident of St. Paul, Bob is committed to participating in strengthening the community. He currently serves on the board of The Tapemark Charity Pro-Am and is chairman of the Hamline University Board of Trustees; additionally, he has been past chair of the school’s Audit Committee and Capital Campaign Committee. He also serves on the board of Minnesota Diversified Industries.
Bob's past community service includes the United Way of the St. Paul Area and Leadership Giving Committee, Family Service, Inc. of St. Paul, Dakota Communities, Inc., Signal Bank, Community Employment Partnership, and The Berres Homes.
Sr. Vice President & COO
As Sr. Vice President & Chief Operating Officer at Tapemark, Beau oversees and directs members of the Leadership Team who are responsible for Research & Development, Manufacturing Operations, and Compliance & Administration. He also has responsibility for Sales, Marketing and Business Development.
Beau has nearly 20 years of pharmaceutical expertise and thoroughly understands the needs of the pharmaceutical maker. He started his career with Boehringer Ingelheim (BI) as a sales representative. From that point, Beau gained experience in sales leadership, brand marketing, national and global market access, large unit leadership, strategic planning, and business development while with BI. A common thread in all of Beau’s assignments with BI was delivering value and innovation through pharmaceutical therapies to the United States’ most complex integrated healthcare delivery systems.
Beau has experience with more than two- dozen therapeutic areas, has sold and marketed 14 branded therapies, and has launched 6 NDAs of which 4 became blockbuster products.
Beau received his undergraduate degree in Economics from The Colorado College and completed his MBA while attending The Carlson School of Management and The Gore School of Business.
VP Chief Compliance & Administrative Officer
Pat Mork is Vice President of Human Resources for Tapemark. Pat joined Tapemark in 1997 as a human resource consultant with a specialty in recruiting and has risen through the organization to her current position as VP. Prior to joining Tapemark, her previous experience includes management support for benefits, recruiting, training, and organizational development for a large, multi-location organization.
As VP of HR, Pat's primary responsibilities are the management of staffing and recruiting, coaching Tapemark’s managers and supervisors, expanding the company’s skill-based training, and promoting employee relations and effective work performance of all employees. She drives employee and leadership development in support of the Tapemark values: Excellence, Responsibility, Integrity, Community, Knowledge, and Attitude. She was responsible for successful oversight of nearly $1 million of training for Tapemark employees, supported by a three-year Minnesota Job Skills Partnership grant.
Additionally, Pat led the establishment of an employee-driven wellness committee that is having a significant impact on the overall health of the Tapemark employee population.
She holds a Bachelor of Arts degree from Metropolitan State University in business administration along with a Senior Professional Human Resources (SPHR) certification. In addition, she has served on the boards of Kaposia and Melpomene.
VP Research and Development
Cormac Lyons has focused on research and development for over 16 years in the pharmaceutical space. He has a rare blend of experience and knowledge in both the technical and business sides of the industry. Cormac has produced successful results in all stages of pharmaceutical development. This includes early development of new technologies, technology transfer, process development, clinical manufacturing, commercial process validation, and commercial product launch.
Cormac has substantive experience with drug and drug-device combination products, small and biomolecules, and complex drug delivery systems such as films, patches, active platforms, and topical forms. He was instrumental in the successful development, approval, and launch of a first-of-a-kind active transdermal product. Cormac has authored scientific papers and patented inventions. In addition to pharmaceuticals, over the course of his career, Cormac has adapted successfully in several other fields, including Renewable Energy, Biosensors, and Novel Displays.
Cormac is driven by the desire to positively influence people's lives. Being a senior manager in a pharmaceutical organization provides him with the opportunity to realize his personal mission by providing drug products that allow people to live healthier and happier lives. As a leader in the organization, Cormac is also driven by a desire to develop people to their fullest potential.
Cormac holds a Doctorate in Chemistry and a Bachelor’s in Science (First Class Honors) in both Physics and Chemistry from Trinity College Dublin. He conducted his Postdoctoral Research at the Massachusetts Institute of Technology.
Jason has served as VP of Operations at Tapemark since 2018. Under this role, he is responsible for providing strategic leadership to Production, Material Management & Supply Chain, Engineering, Facilities, and Maintenance. He joined Tapemark in 2014, serving the company in a number of roles between then and now. He brings 15 years of pharmaceutical industry experience to the Tapemark leadership team.
Prior to joining Tapemark, Jason was with Cima Labs (Teva Pharmaceuticals) where he was responsible for analytical method development, validation, and transfer activities for oral solid and abuse-deterrent dosage forms. Prior to Cima, he was at PRACS Institute (QPS) in Fargo, N.D. developing and validating bioanalytical assay methods for the clinical team and leading skin permeation studies on topical and transdermal formulations for the pre-clinical team.
Jason holds an MBA from the University of Minnesota and a Bachelor of Science Degree in Chemistry from North Dakota State University.
Sr. Vice President & CFO
Dave O’Brien is Tapemark’s Senior Vice President and Chief Financial Officer. Dave has provides effective leadership over many years as Tapemark has grown and positioned itself for success in new and various business markets. Dave is a longterm employee of Tapemark, joining the company in 1979. He served as Staff Accountant and Controller prior to his promotion to CFO in 2006.
In his role as Chief Financial Officer, his responsibilities include capital planning, strategic planning, financial analysis and reporting, treasury management, tax compliance, insurance and risk management, shareholder relations, and IT. Over the years he has played an extensive role in external audits, systems implementation, costing and pricing systems, and business process automation.
Dave holds a Bachelor of Arts degree in Accounting from Gustavus Adolphus College. He currently serves on the boards of The Tapemark Company and the Tapemark Charity Pro-Am. Previous community experience includes serving on the Boards of ARC St. Paul and DARTS.